What Is INCY Fair Value?
Incyte (INCY) fair value estimate using multiple valuation models, updated daily.
As of October 14, 2026, Incyte (INCY) has a composite fair value estimate of $81.98 based on four valuation models: DCF (41% weight), Graham Number (29% weight), PEG (29% weight), and DDM (0% weight). The current market price is $108.62, suggesting the stock is overvalued by 24.5%.
Data as of October 14, 2026 (today)
Composite Fair Value
Overvalued3 of 4 models$81.98
vs. current price of $108.62(-24.5%)
How Is INCY Fair Value Calculated?
Four independent models estimate what INCY is worth. Each uses different inputs and assumptions. The composite blends them by weight.
INCY Intrinsic Value
Forward-looking models based on future cash flows
DCF (Discounted Cash Flow)
41% weightEstimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →
$120.32
+10.8%Fair Value
Inputs used
DDM (Dividend Discount Model)
0% weightIf a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →
N/A
This stock does not pay a dividend, so the DDM cannot be applied. The composite adjusts by redistributing this weight to the other models.
INCY Fair Value
Current fundamentals: earnings, assets, and growth rate
Graham Number (Value Investing)
29% weightCreated by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →
$48.05
-55.8%Overvalued
Inputs used
PEG (Price/Earnings to Growth)
29% weightChecks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.
$32.50
-70.1%Overvalued
Inputs used
What If You Change the Assumptions?
Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.
Your DCF Fair Value
Current price $108.62 is 10.8% below this estimate
View 10-year cash flow projections
| Year | Projected FCF (Free Cash Flow) | Present Value |
|---|---|---|
| Year 1 | $1.24B | $1.14B |
| Year 2 | $1.30B | $1.10B |
| Year 3 | $1.37B | $1.07B |
| Year 4 | $1.44B | $1.03B |
| Year 5 | $1.51B | $999.5M |
| Year 6 | $1.58B | $966.8M |
| Year 7 | $1.66B | $935.1M |
| Year 8 | $1.74B | $904.5M |
| Year 9 | $1.83B | $874.8M |
| Year 10 | $1.92B | $846.2M |
| Terminal Value | $32.55B | $14.32B |
What Are INCY's Key Financial Metrics?
Earnings & Growth
Current Price
$108.62
EPS (TTM)
$7.85
Forward P/E
12.5
Profit Margin
27.7%
Cash & Balance Sheet
Free Cash Flow
1.2B
EBITDA
1.9B
Book Value
$31.57
Total Debt
38.3M
What Do Analysts Say About INCY?
Low
$86.00
Average
$129.13
High
$157.00
Upside
+18.9%
INCY Fair Value FAQ
What is the fair value of INCY?
Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), INCY's estimated fair value is $81.98. The stock is currently trading at $108.62, which makes it overvalued by our analysis.
How is INCY's fair value calculated?
We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.
Is INCY overvalued or undervalued?
Based on our analysis, INCY is overvalued. The current price of $108.62 is 24.5% above our estimated fair value of $81.98.
What do Wall Street analysts say about INCY?
24 analysts cover Incyte with a consensus rating of "Buy." The average price target is $129.13, ranging from $86.00 to $157.00. This implies 18.9% upside from the current price.